{"id":"W2521232714","doi":"10.1017/cjn.2016.289","title":"Open-Label Study of Sleep Disturbances in Patients with Parkinson’s Disease Treated with Rasagiline","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"GDI Integrated Facility Services (Canada); Terahertz Technology Solutions (Canada); Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"Novartis Pharma; Institut de Cardiologie de Montréal; Teva Pharmaceutical Industries","keywords":"Rasagiline; Medicine; Tolerability; Epworth Sleepiness Scale; Clinical Global Impression; Quality of life (healthcare); Physical therapy; Parkinson's disease; Clinical trial; Internal medicine; Adverse effect; Disease; Polysomnography; Placebo","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003299543,0.001511131,0.003607296,0.0005584448,0.0006920501,0.0007292743,0.0007585515,0.001438136,0.004318832],"category_scores_gemma":[0.002236524,0.0005576913,0.00134801,0.0005812072,0.001259309,0.001103154,0.0004945985,0.002513158,0.0009237292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004975153,"about_ca_system_score_gemma":0.001179093,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005606806,"about_ca_topic_score_gemma":0.001142299,"domain_scores_codex":[0.9983178,0.0009780747,0.0001472199,0.0002083971,0.0002158755,0.0001326108],"domain_scores_gemma":[0.9970111,0.0007711018,0.0007311027,0.0003378895,0.0003373447,0.000811512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8669353,0.06784545,0.01248341,0.0008528834,0.001121462,0.0001400549,0.000346457,0.0004594356,0.01356333,0.00007292087,0.0007333485,0.03544604],"study_design_scores_gemma":[0.3302196,0.6352196,0.03072762,0.00003106039,0.0003530578,0.0001132959,0.0000630578,0.0007318789,0.001139389,0.00005091638,0.001318269,0.00003229991],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930507,0.001213439,0.0004476612,0.0001256712,0.0001289884,0.003305678,0.0007791094,0.00005425099,0.0008944869],"genre_scores_gemma":[0.9877251,0.0009007595,0.00189217,0.0004241944,0.0003910956,0.005855834,0.001447207,0.0000131306,0.001350403],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004318832,"threshold_uncertainty_score":0.01744992,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03137363611357772,"score_gpt":0.2696121847811537,"score_spread":0.238238548667576,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}